Kenya · Delayed Price · Currency is KES Car & General (Kenya) Statistics
Total Valuation
NASE:CGEN has a market cap or net worth of KES 21.33 billion. The enterprise value is 27.89 billion.
| Market Cap | 21.33B |
| Enterprise Value | 27.89B |
Important Dates
The last earnings date was Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | Sep 4, 2026 |
Share Statistics
NASE:CGEN has 80.21 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 80.21M |
| Shares Outstanding | 80.21M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 11.15% |
| Owned by Institutions (%) | n/a |
| Float | 10.33M |
Valuation Ratios
The trailing PE ratio is 4.85.
| PE Ratio | 4.85 |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | 11.62 |
| P/OCF Ratio | 9.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.91, with an EV/FCF ratio of 15.20.
| EV / Earnings | 6.34 |
| EV / Sales | 0.96 |
| EV / EBITDA | 4.91 |
| EV / EBIT | 5.23 |
| EV / FCF | 15.20 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.09 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 3.89 |
| Interest Coverage | 2.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.56% |
| Return on Capital Employed (ROCE) | 14.58% |
| Weighted Average Cost of Capital (WACC) | 6.33% |
| Revenue Per Employee | 22.62M |
| Profits Per Employee | 3.44M |
| Employee Count | 1,280 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NASE:CGEN has paid 632.91 million in taxes.
| Income Tax | 632.91M |
| Effective Tax Rate | 12.54% |
Stock Price Statistics
The stock price has increased by +624.80% in the last 52 weeks. The beta is 0.12, so NASE:CGEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +624.80% |
| 50-Day Moving Average | 218.08 |
| 200-Day Moving Average | 108.07 |
| Relative Strength Index (RSI) | 50.19 |
| Average Volume (20 Days) | 18,562 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NASE:CGEN had revenue of KES 28.95 billion and earned 4.40 billion in profits. Earnings per share was 54.84.
| Revenue | 28.95B |
| Gross Profit | 5.50B |
| Operating Income | 2.02B |
| Pretax Income | 5.05B |
| Net Income | 4.40B |
| EBITDA | 2.24B |
| EBIT | 2.02B |
| Earnings Per Share (EPS) | 54.84 |
Balance Sheet
The company has 878.20 million in cash and 7.15 billion in debt, with a net cash position of -6.27 billion or -78.18 per share.
| Cash & Cash Equivalents | 878.20M |
| Total Debt | 7.15B |
| Net Cash | -6.27B |
| Net Cash Per Share | -78.18 |
| Equity (Book Value) | 10.49B |
| Book Value Per Share | 127.28 |
| Working Capital | 947.23M |
Cash Flow
In the last 12 months, operating cash flow was 2.35 billion and capital expenditures -515.21 million, giving a free cash flow of 1.84 billion.
| Operating Cash Flow | 2.35B |
| Capital Expenditures | -515.21M |
| Depreciation & Amortization | 220.26M |
| Net Borrowing | -1.11B |
| Free Cash Flow | 1.84B |
| FCF Per Share | 22.88 |
Margins
Gross margin is 19.00%, with operating and profit margins of 6.99% and 15.19%.
| Gross Margin | 19.00% |
| Operating Margin | 6.99% |
| Pretax Margin | 17.44% |
| Profit Margin | 15.19% |
| EBITDA Margin | 7.75% |
| EBIT Margin | 6.99% |
| FCF Margin | 6.34% |
Dividends & Yields
This stock pays an annual dividend of 3.42, which amounts to a dividend yield of 1.41%.
| Dividend Per Share | 3.42 |
| Dividend Yield | 1.41% |
| Dividend Growth (YoY) | 274.55% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 6.24% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 1.19% |
| Earnings Yield | 20.61% |
| FCF Yield | 8.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 25, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Mar 25, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NASE:CGEN has an Altman Z-Score of 2.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 3 |